EditorialAnn Transl Med2025
GEMPAX, do we have another second-line option after mFOLFIRINOX in pancreatic cancer?
- Journal
- Ann Transl Med
- Published
- 25 February 2025
- Citations
- 0
- Type
- Editorial
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try